Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Simultaneous EV71 and Influenza Vaccination in Infants
NCT04091880Phase 4Completed
- Sponsor
- China National Biotec Group
- Start
- Sep 2019
- Primary completion
- Jan 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of inactivated enterovirus 71 vaccine, influenza vaccine in enterovirus infection, influenza, sponsored by China National Biotec Group. Started Sep 2019; status: completed.
02
Drugs
inactivated enterovirus 71 vaccineinfluenza vaccine
03
Conditions
enterovirus infectioninfluenza
Beyond the preview
Go deeper on NCT04091880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04091880.